Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Treasury Shares (2022 - 2025)

Historic Treasury Shares for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $2.6 million.

  • Orchestra BioMed Holdings' Treasury Shares rose 1101.92% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 1101.92%. This contributed to the annual value of $2.1 million for FY2024, which is 2312.33% up from last year.
  • Latest data reveals that Orchestra BioMed Holdings reported Treasury Shares of $2.6 million as of Q3 2025, which was up 1101.92% from $2.2 million recorded in Q2 2025.
  • Over the past 5 years, Orchestra BioMed Holdings' Treasury Shares peaked at $3.9 million during Q1 2023, and registered a low of $49237.0 during Q2 2023.
  • In the last 4 years, Orchestra BioMed Holdings' Treasury Shares had a median value of $2.0 million in 2024 and averaged $1.9 million.
  • Data for Orchestra BioMed Holdings' Treasury Shares shows a peak YoY increase of 492830.39% (in 2024) and a maximum YoY decrease of 5695.15% (in 2024) over the last 5 years.
  • Over the past 4 years, Orchestra BioMed Holdings' Treasury Shares (Quarter) stood at $158589.0 in 2022, then surged by 972.72% to $1.7 million in 2023, then rose by 23.12% to $2.1 million in 2024, then increased by 25.42% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, $2.2 million for Q2 2025, and $1.9 million during Q1 2025.